Citadel Advisors - ALTAMIRA THERAPEUTICS LTD ownership

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 20 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2022$30,000
+57.9%
104,120
+161.6%
0.00%
Q2 2022$19,000
-82.7%
39,800
-60.3%
0.00%
Q1 2022$110,000
+29.4%
100,200
+112.7%
0.00%
Q4 2021$85,000
-26.7%
47,100
-18.2%
0.00%
Q3 2021$116,00057,5720.00%
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 320,010$351,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 30,753$34,0000.00%
Cutler Group LLC / CA 2,100$2,0000.00%
BARCLAYS PLC 1$00.00%
Gradient Investments LLC 1,000$1,0000.00%
Stonebridge Capital Advisors LLC 100$00.00%
UBS Group AG 3,486$4,0000.00%
OSAIC HOLDINGS, INC. 10$00.00%
WELLS FARGO & COMPANY/MN 500$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders